TIMONY, GREGG,GUJRATHI, SHEILA,PEACH, ROBERT,OLSON, ALLAN
申请号：
CA3021334
公开号：
CA3021334A1
申请日:
2017.04.27
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention is directed to methods for treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment, a composition containing an inter leukin- 13 (IL-13) antibody, or an antigen binding fragment, thereof.
